Delivery Order SPE2DB22D2103-SPE2DB24FR8NV
Award Date 11/21/23
Potential Completion Date 11/22/23
Potential Value $18K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a leading global pharmaceutical sourcing and distribution company, to supply Prevnar 13 syringes. The $9,099.03 contract, which has an ultimate completion date of March 15, 2024, is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp with a potential value of $999,999,999.00 through December 31, 2025. This IDC serves as the primary...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $16,275.33 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the delivery of PREVNAR 13 syringes, with a performance period through March 26, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $2,274.80 to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company. The contract is for the delivery of PREVNAR 13 SYRINGE 0.5ML, a vaccine product, with a completion date of February 14, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp by DLA, with a potential value of...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of PREVNAR 13 syringes. The contract has a ceiling value of $5,203.76 and a performance period through March 20, 2024. This award is a task order under a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, which has a potential value of $999,999,999.00 and a period of performance through...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide PREVNAR 13 SYRINGE 0.5ML. The award has a potential value of $6,995.45 and a completion date of November 7, 2023. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,616.04 firm fixed-price contract is for the supply of Prevnar 13 syringes (0.5mL). The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $30,950.25 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PREVNAR 13 SYRINGE 0.5ML, a vaccine product, with an ultimate completion date of January 16, 2024. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds...
- This is a $13,593.83 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of PREVNAR 13 SYRINGE 0.5ML, a pneumococcal conjugate vaccine, with a period of performance through March 5, 2024. The contract has a Firm Fixed Price pricing type and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of PREVNAR 13 syringes (0.5 ml) to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, as a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $2,739.73 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the supply of PREVNAR 13 SYRINGE 0.5ML, a vaccine product, with a period of performance through January 30, 2024. This delivery order is issued under Amerisourcebergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA, which has...
- SPE2DB22D2103Indefinite Delivery Contract
- SPE2DB22D2103-SPE2DB24FR8NVDelivery Order
The Defense Logistics Agency (DLA) awarded a $17,987.29 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PREVNAR 13 SYRINGE 0.5ML. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has an ultimate completion date of November 22, 2023 and was awarded on November 21, 2023. The contract does not have a set-aside designation, indicating it was awarded through open competition.
Generated 5/12/25, 10:28 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.0k | 11/21/23 |